IMDS nasdaq bulletin board Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : IMDS nasdaq bulletin board

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dan O who wrote (3400)	6/1/1999 7:37:00 PM
From: Andrew Abraham	Read Replies (2) of 4122

Dan O, I just noticed that IMDS' Web site continues to claim that the company owns the CTLM patent. Dan, what's the truth about this? Have you (or anyone) gotten a copy of the patent from the U.S. Patent Office? From IMDS' Web site: imds.com CTLM Patent Imaging Diagnostic Systems, Inc. Has Been Granted Approval of the CTLM Patent with Additional 23 Claims ''The patent is expected to provide protection of many of the proprietary mechanical, electronic, and optical features of the CTLM scanner,'' said Richard Grable, CEO and a developer of the technology. ''The patent application was filed in 1995 and covered the discoveries made in the first year of the company's existence. IDSI has filed 8 additional patent applications since the original filing. These are also based on discoveries made during product development.'' The CTLM is a revolutionary device that uses innovative laser technology to produce three-dimension and cross-section images of the breast. It is currently being tested in the first phase of human trials under FDA approved IDE program. The testing will evaluate the clinical effectiveness of CTLM as a potential diagnostic tool that does not require breast compression and does not use x-ray. Patent Number Issued For Imaging Diagnostic Systems, Inc. FORT LAUDERDALE, Fla., Nov. 13 /PRNewswire/ -- Imaging Diagnostic Systems (OTC Bulletin Board: IMDS) announced today that the Company has received an issue of notification from the United States Department of Commerce Patent and Trademark Office for the Company's breast imaging device, the CTLMTM. The Patent Number is 5692511 and will be issued on December 2, 1997. Imaging Diagnostic Systems has developed the world's first breast-imaging device that utilizes state-of-the-art laser technology and proprietary computer algorithms to produce three-dimensional cross-sectional slice images of the breast.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next